Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Fibroblast-Selective Lipid Nanoparticles for Tumor Stromal Transfection.

Molecular pharmaceutics·2026

Same journal

Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention.

Molecular pharmaceutics·2026

Same journal

Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding.

Molecular pharmaceutics·2026

Same journal

Evaluation of <sup>161</sup>Tb-Labeled DOTA-Ibandronate for Targeted Radionuclide Therapy in Bone Metastases.

Molecular pharmaceutics·2026

Same journal

Drug Delivery-Enabled Antibiofilm Therapeutics from Traditional Chinese Medicine-Derived Bioactives: Recent Advances and Future Perspectives.

Molecular pharmaceutics·2026

Same journal

Radiolabeled Mesoporous Silica Nanosystem Enables Long-Term Cell Tracking In Vivo.

Molecular pharmaceutics·2026

Search research articles

Related Experiment Video

Updated: May 13, 2025

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

Smart SPIONs for Multimodal Cancer Theranostics: A Review.

Pradip Pawar¹, Arati Prabhu¹

¹SVKM's Dr. Bhanuben Nanavati College of Pharmacy, 400056 Mumbai, India.

Molecular Pharmaceutics

|April 14, 2025

Summary

Superparamagnetic iron oxide nanoparticles (SPIONs) offer a promising hybrid approach for cancer therapy, enhancing treatment efficacy and safety. These nanoparticles enable multimodal therapies for improved tumor mitigation and precision medicine.

Keywords:

SPIONs cancer magnetic hyperthermia magnetic nanoparticles photodynamic therapy photothermal therapy

More Related Videos

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Related Experiment Videos

Last Updated: May 13, 2025

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Area of Science:

Biomedical Engineering
Nanotechnology
Oncology

Background:

Current cancer treatments face challenges including metastasis, drug resistance, and severe side effects.
There is an urgent need for safer and more effective tumor mitigation strategies.

Purpose of the Study:

To explore the application of superparamagnetic iron oxide nanoparticles (SPIONs) in hybridized cancer therapy.
To review SPIONs' role in enhancing treatment efficacy and safety for precision medicine.

Main Methods:

Utilizing SPIONs as platforms for multimodal cancer therapeutics.
Integrating physical phenomena (light, heat, sound, magnetism) with nanoparticulate delivery systems.
Leveraging SPIONs for enhanced diagnostic applications like magnetic resonance imaging.

Main Results:

SPIONs demonstrate versatility for various therapeutic and diagnostic applications.
Hybridized therapies show potential for targeted cancer treatment.
Noninvasive platforms like photodynamic, photothermal, magnetic hyperthermia, and sonodynamic therapies are promising.

Conclusions:

SPIONs represent a significant advancement in developing safer and more effective cancer therapeutics.
Hybridized and multimodal approaches using SPIONs hold great promise for overcoming current challenges in cancer treatment.